NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results